Severe Infusion Reactions to Fabry Enzyme Replacement Therapy: Rechallenge After Tracheostomy

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

Christine M. Eng, Nathalie Guffon, William R. Wilcox et al. · New England Journal of Medicine · 2001 · 1.5K citations · Full text

Medicine, Clinical Sciences, Pharmacology +14

Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease

William R. Wilcox, Maryam Banikazemi, Nathalie Guffon et al. · The American Journal of Human Genetics · 2004 · 405 citations · Full text

Life Sciences, Pharmacotherapy, Renal Replacement Therapy +7

A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety Studies

Christine M. Eng, Maryam Banikazemi, Ronald E. Gordon et al. · The American Journal of Human Genetics · 2001 · 383 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Enzyme therapy for Fabry disease: Neutralizing antibodies toward agalsidase alpha and beta

Gabor E. Linthorst, Carla E. M. Hollak, Wilma E. Donker‐Koopman et al. · Kidney International · 2004 · 281 citations

Life Sciences, Biochemistry, Molecular Biology +9

Enzyme-Replacement Therapy With Agalsidase Alfa in Children With Fabry Disease

Markus Ries, Joe T.R. Clarke, Catharina Whybra et al. · PEDIATRICS · 2006 · 162 citations

Life Sciences, Pediatrics, Pharmacotherapy +12